Maine Rx Rebate Program Stayed As PhRMA Mulls Supreme Court Case
Executive Summary
The Maine Rx Program will be prevented from going into effect until the end of July as the Pharmaceutical Research & Manufacturers of America considers whether it should pursue its case against the program to the U.S. Supreme Court.
You may also be interested in...
PhRMA v. Maine
Supreme Court requests brief from U.S. Solicitor General Theodore Olson before deciding whether to hear the Pharmaceutical Research & Manufacturers of America's case against the Maine drug discount program. Sen. Olympia Snowe (R-Maine) asks Olson in an Oct. 10 letter to request that the court not review the case, which would allow Maine to proceed with implementation of the program (1"The Pink Sheet" July 9, p. 3)
PhRMA v. Maine
Supreme Court requests brief from U.S. Solicitor General Theodore Olson before deciding whether to hear the Pharmaceutical Research & Manufacturers of America's case against the Maine drug discount program. Sen. Olympia Snowe (R-Maine) asks Olson in an Oct. 10 letter to request that the court not review the case, which would allow Maine to proceed with implementation of the program (1"The Pink Sheet" July 9, p. 3)
Florida Medicaid Formulary Challenged By PhRMA Lawsuit
Florida will continue implementation of state Medicaid supplemental rebate law pending a hearing on PhRMA's preliminary injunction request seeking to block the program.